Literature DB >> 19876600

Intrathecal liposomal cytarabine in combination with temozolomide in low-grade oligoastrocytoma with leptomeningeal dissemination.

Maria Grazia Passarin1, Giuseppe Moretto, Anna Maria Musso, Sarah Ottaviani, Barbara Masotto, Claudio Ghimenton, Paolo Iuzzolino, Ebba Buffone, Roberta Rudà, Riccardo Soffietti, Emanuela Vattemi, Rebecca Pedersini.   

Abstract

Leptomeningeal dissemination of low-grade gliomas is an uncommon event. A 43-year old male presented with dizziness, gait ataxia, and diplopia. A nonenhancing lesion in the right cerebellar peduncle was identified, subtotally resected, and diagnosed as a grade II astrocytoma. After one year a nodular spread in the brain and leptomeninges was diagnosed, so the patient started chemotherapy with temozolomide and liposomal cytarabine. Complete remission was achieved after 12 months of treatment and the patient is still free from the disease after a follow-up of 24 months. We suggest that this combination may be a valuable treatment option.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19876600     DOI: 10.1007/s11060-009-0040-0

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  15 in total

Review 1.  Clinical pharmacology of encapsulated sustained-release cytarabine.

Authors:  D J Murry; S M Blaney
Journal:  Ann Pharmacother       Date:  2000-10       Impact factor: 3.154

Review 2.  Neoplastic meningitis.

Authors:  Marc C Chamberlain
Journal:  J Clin Oncol       Date:  2005-05-20       Impact factor: 44.544

3.  Phase II trial of temozolomide in patients with progressive low-grade glioma.

Authors:  Jennifer A Quinn; David A Reardon; Allan H Friedman; Jeremy N Rich; John H Sampson; James M Provenzale; Roger E McLendon; Sridharan Gururangan; Darell D Bigner; James E Herndon; Nicholas Avgeropoulos; Jonathan Finlay; Sandra Tourt-Uhlig; Mary Lou Affronti; Brandon Evans; Valerie Stafford-Fox; Sara Zaknoen; Henry S Friedman
Journal:  J Clin Oncol       Date:  2003-02-15       Impact factor: 44.544

4.  An open label trial of sustained-release cytarabine (DepoCyt) for the intrathecal treatment of solid tumor neoplastic meningitis.

Authors:  Kurt A Jaeckle; Tracy Batchelor; Steven J O'Day; Surasak Phuphanich; Pamela New; Glenn Lesser; Allen Cohn; Mark Gilbert; Robert Aiken; Deborah Heros; Lisa Rogers; Eric Wong; Dorcas Fulton; John C Gutheil; Said Baidas; Julia M Kennedy; Warren Mason; Paul Moots; Christy Russell; Lode J Swinnen; Stephen B Howell
Journal:  J Neurooncol       Date:  2002-05       Impact factor: 4.130

5.  Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas.

Authors:  M Brada; L Viviers; C Abson; F Hines; J Britton; S Ashley; S Sardell; D Traish; A Gonsalves; P Wilkins; C Westbury
Journal:  Ann Oncol       Date:  2003-12       Impact factor: 32.976

6.  Plasma and cerebrospinal fluid population pharmacokinetics of temozolomide in malignant glioma patients.

Authors:  Sandrine Ostermann; Chantal Csajka; Thierry Buclin; Serge Leyvraz; Ferdy Lejeune; Laurent A Decosterd; Roger Stupp
Journal:  Clin Cancer Res       Date:  2004-06-01       Impact factor: 12.531

7.  Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions.

Authors:  K Hoang-Xuan; L Capelle; M Kujas; S Taillibert; H Duffau; J Lejeune; M Polivka; E Crinière; Y Marie; K Mokhtari; A F Carpentier; F Laigle; J M Simon; P Cornu; P Broët; M Sanson; J Y Delattre
Journal:  J Clin Oncol       Date:  2004-08-01       Impact factor: 44.544

8.  Leptomeningeal dissemination in children with progressive low-grade neuroepithelial tumors.

Authors:  Juliette Hukin; Joao Siffert; Linda Velasquez; David Zagzag; Jeffrey Allen
Journal:  Neuro Oncol       Date:  2002-10       Impact factor: 12.300

Review 9.  Leptomeningeal dissemination of low-grade intramedullary gliomas: about one case and review.

Authors:  Nicky D'Haene; Nicolas Coen; Carine Neugroschl; Danielle Balériaux; Isabelle Salmon
Journal:  Clin Neurol Neurosurg       Date:  2009-01-06       Impact factor: 1.876

10.  Pharmacokinetics of intralumbar DTC-101 for the treatment of leptomeningeal metastases.

Authors:  M C Chamberlain; P Kormanik; S B Howell; S Kim
Journal:  Arch Neurol       Date:  1995-09
View more
  4 in total

Review 1.  Biology and therapy of neoplastic meningitis.

Authors:  Aaron G Mammoser; Morris D Groves
Journal:  Curr Oncol Rep       Date:  2010-01       Impact factor: 5.075

Review 2.  Neoplastic meningitis from solid tumors: new diagnostic and therapeutic approaches.

Authors:  Giuseppe Lombardi; Fable Zustovich; Patrizia Farina; Alessandro Della Puppa; Renzo Manara; Diego Cecchin; Antonella Brunello; Alessandro Cappetta; Vittorina Zagonel
Journal:  Oncologist       Date:  2011-07-27

3.  Liposomal cytarabine in neoplastic meningitis from primary brain tumors: a single institutional experience.

Authors:  P Gaviani; E Corsini; A Salmaggi; E Lamperti; A Botturi; A Erbetta; I Milanesi; F Legnani; B Pollo; A Silvani
Journal:  Neurol Sci       Date:  2013-03-24       Impact factor: 3.307

4.  Leptomeningeal dissemination of low-grade neuroepithelial CNS tumors in adults: a 15-year experience.

Authors:  Philipp Karschnia; Frank J Barbiero; Michaela H Schwaiblmair; Leon D Kaulen; Joseph M Piepmeier; Anita J Huttner; Kevin P Becker; Robert K Fulbright; Joachim M Baehring
Journal:  Neurooncol Pract       Date:  2019-07-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.